Suspension of trading
Quotes Acorda Therapeutics OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0135 USD | -3.57% |
|
-10.00% | -99.91% |
| 24-08-13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 24-08-07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
Performance
| 1 week | -10.00% | ||
| 1 month | -87.85% | ||
| 3 months | -98.41% | ||
| 6 months | -99.90% | ||
| Current year | -99.91% | ||
| 1 year | -99.92% | ||
| 3 years | -99.98% | ||
| 5 years | -100.00% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
16,768
Free-Float
99.33 %
Free-Float capitalization (USD)
16,660
Indicators
Moving average 5 days
0.0159
Moving average 100 days
0.5599
Price spread / (MMA5)
+17.78%
Price spread / (MMA100)
+4,047.41%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.57% | -10.00% | -99.92% | -99.98% | 16.77K | |
| +0.68% | +5.92% | +77.86% | +139.22% | 59.1B | |
| +2.32% | +5.03% | +75.26% | +91.40% | 55.19B | |
| +3.86% | +6.93% | -11.32% | -9.53% | 24.67B | |
| +4.30% | +7.95% | +14.11% | +437.83% | 24.19B | |
| +4.74% | +13.68% | +43.36% | -4.67% | 19.69B | |
| -0.29% | +9.78% | +43.90% | -28.41% | 17.56B | |
| 0.00% | +20.78% | +186.15% | +361.42% | 16.22B | |
| +6.72% | +19.38% | +37.85% | - | 14.84B | |
| +3.50% | +1.97% | +21.02% | +191.95% | 14.04B | |
| Average | +2.87% | +8.57% | +38.83% | +119.91% | 24.55B | |
| Weighted average by Cap. | +2.46% | +6.47% | +58.32% | +136.98% |
Historical Quotes: Acorda Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.01 |  | 0.02 |
| 1 month | 0.01 | | 0.15 |
| 3 years | 0.01 | | 99.8 |
| 5 years | 0.01 | | 535.2 |
Monthly variations
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
- Quotes Acorda Therapeutics
Select your edition
All financial news and data tailored to specific country editions
